Groeneveld, G. J.

Physical activity and the association with sporadic ALS

Veldink, J. H., Kalmijn, S., Groeneveld, G. J., Titulaer, M. J., Wokke, J. H. J., & van den Berg, L. H. (2005) · Neurology

Amyotrophic Lateral Sclerosis ResearchPhysical Activity and Health

Cited by 135

Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis

van Amerongen, G., Kanhai, K., Baakman, A. C., Heuberger, J., Klaassen, E., Beumer, T. L., Strijers, R. L. M., Killestein, J., van Gerven, J., Cohen, A., et al. (2018) · Clinical Therapeutics

Cannabis and Cannabinoid ResearchMultiple Sclerosis Research Studies

Cited by 86

Few Adverse Effects of Long-Term Creatine Supplementation in a Placebo-Controlled Trial

Groeneveld, G. J., Beijer, C., Veldink, J. H., Kalmijn, S., Wokke, J. H. J., & van den Berg, L. H. (2005) · International Journal of Sports Medicine

Muscle metabolism and nutritionBiochemical effects in animals

Cited by 64

The Use of Biomarkers in Human Pharmacology (Phase I) Studies

Cohen, A. F., Burggraaf, J., van Gerven, J. M. A., Moerland, M., & Groeneveld, G. J. (2015) · Annual Review of Pharmacology and Toxicology

Statistical Methods in Clinical TrialsPharmaceutical studies and practices

Cited by 55

The impact of the global COVID-19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis

Vissers, M. F. J. M., Cohen, A. F., Van Gerven, J. M. A., & Groeneveld, G. J. (2021) · British Journal of Clinical Pharmacology

Ethics in Clinical ResearchCOVID-19 and healthcare impacts

Cited by 25